Navigation Links
sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011
Date:4/28/2011

pression and was discontinued. Sanofi-aventis has decided to exercise its right to terminate the license agreement with Metabolex regarding SAR260093/MBX-2982 (GPR119 receptor agonist). 

Several regulatory milestones were reached during the period:

  • In March, the European Commission granted marketing authorization for Jevtana® in combination with prednisone/prednisolone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing regimen. Jevtana® is the first approved agent to significantly extend overall survival in mHRPC patients whose disease has progressed during or after treatment containing docetaxel.
  • In April, the FDA has granted licensure to expand the indication for Menactra®, a meningococcal conjugate vaccine, to include a two-dose schedule for infants and children 9 months through 23 months of age. This is the first U.S. approval of a meningococcal vaccine for this age group.

  • Three collaborations were also announced:

  • In February, Sanofi Pasteur, the vaccines division of sanofi-aventis announced that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative. Sanofi Pasteur and the IVI will aim to raise awareness and to work to move dengue vaccination higher on the global health agenda.
  • In March, sanofi-aventis announced the signing of a cooperation agreement between Fovea Pharmaceuticals, its Ophthalmology Division, and the Vision Institute (Institut de la Vision), one of the main eye disease research centers in Europe, for research in the diagnosis, prevention and treatment of ocular diseases. This agreement aims to set up a privileged partnership between sanofi-aventis and the Vision Institute on the model of translational R&D and to strengthen the collaboration of sanofi-aventis with the bodies constituting the Vision Ins
    '/>"/>

  • SOURCE sanofi-aventis
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

    Related medicine technology :

    1. Sanofi-aventis: Multaq(R) Approved in the European Union for Patients With Atrial Fibrillation
    2. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    3. Reportlinker Adds Sanofi-Aventis: PharmaVitae Profile
    4. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
    5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
    8. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
    9. US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
    10. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
    11. Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of Mr. C Causes Major Interest in the Scientific Community
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... Sept. 3, 2015 About self-monitoring blood ... a home-based electronic device. It consists of a ... about glucose levels through radiowaves from the sensor ... regular usage of self-monitoring blood glucose devices can ... to undergo proper diabetes treatment. Technavio,s ...
    (Date:9/3/2015)... 2015 About cardiovascular implants ... narrowing or blockage of blood vessels. Cardiac disease ... high cholesterol, and high blood pressure. Coronary artery ... heart failure are some of the major cardiac ... especially coronary arteries, is one of the most ...
    (Date:9/3/2015)... , Sept. 3, 2015 About dry eye syndrome ... eyes due to deficient tear production or quick tear ... of two types: aqueous tear deficient dry eye and ... lacrimal glands do not produce enough tears, whereas meibomian ... secrete lipids to slow tear evaporation and maintain tear ...
    Breaking Medicine Technology:Global Self-monitoring Blood Glucose Devices Market 2015-2019 2Global Cardiovascular Implants Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2
    (Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a variety ... visits which affects hospitals’ abilities to provide quality service to those with serious needs, ... this problem has recently presented itself, the new telemedicine platform and app, DocChat ...
    (Date:9/4/2015)... ... 2015 , ... ECC announces the site selection and commencement ... with intellectual, developmental and acquired disabilities. The first community, named Luna Azul, will ... homes. In this community, adults will live safely and permanently in homes owned ...
    (Date:9/4/2015)... ... ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and final ... meters final, with an impressive 44.89 seconds at the 2015 North American, Central American ... August 2015. The 44.64 time is a new NACAC Championship record. , Recent ...
    (Date:9/4/2015)... ... September 04, 2015 , ... Steven ... South Glastonbury, Connecticut, has been selected for the Residential Award of Merit by ... and resiliency measures. Chosen from a highly competitive field of submissions, the net-zero ...
    (Date:9/4/2015)... , ... September 04, 2015 , ... ... pale in comparison to settlements under the Stark physician self-referral law. “Stark ... Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals ...
    Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
    ... , , , ... (Nasdaq: ARAY ), a global leader in the field ... Memorial Hospital in Elmhurst, Ill., has installed the CyberKnife((R)) Robotic Radiosurgery ... marks the first installation of this new CyberKnife configuration option, which ...
    ... HATBORO, Pa., July 24 Healthcare Informatics Associates (HIA), ... it has been selected by Hilo Medical Center (HMC) in Hilo, ... system across the East Hawaii Region facilities. , ... ) , , Hilo initially selected ...
    ... PITTSBURGH, July 24 Sick people are being used as a ... pair of patient flow experts. , , ... from ER hallways to hallways on unit floors, believing that will ... Sanzo and Lisa Romano, CEO and Vice President, respectively, at TeleTracking ...
    ... , , , ... hosted by the Kaiser Permanente Health Care Institute and the National ... for all Americans. Speakers discussed proven strategies for incentivizing coordinated care ... the way we cover health care, without actually reforming care delivery ...
    ... In ... through Any Lab Test Now®. , ... TX (PRWEB) July 24, 2009 -- This down economy may be the bane of most American ... 2008, Any Lab Test Now® in Plano has found success in a revolutionary approach ...
    ... People with potentially ,stigmatizing, medical conditions are just as likely ... information to be used for health research. A new study, ... , found that the purpose of the research and the ... determining patients, consent choices. In particular, they were very ...
    Cached Medicine News:Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 2Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 3Health News:First Customer Installs CyberKnife System in Existing Radiation Therapy Vault 4Health News:Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation 2Health News:Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation 3Health News:Are Patients Becoming Victims in Hospital Overcrowding Turf Wars? Experts Ask 2Health News:Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs 2Health News:Teamwork, Technology, and Coordinated Care Improve Outcomes and Lower Costs 3Health News:Cost-Conscious Texans Find Relief with Direct Access Lab Testing 2Health News:Embarrassing illnesses no bar to information sharing 2
    Richardson Retractors...
    Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
    Inquire...
    ... Advanta™ PTFE facial implant is an ... for augmentation or repair of the ... product is available in sheets and ... PTFE round facial implant strands are ...
    Medicine Products: